Article
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry.
Journal of virology - 1 Mar 2005
Das Atze T, Baldwin Chris E, Vink Monique, Berkhout Ben
Abstract excerpt
Live attenuated human immunodeficiency virus type 1 (HIV-1) vaccines are considered unsafe because faster-replicating pathogenic virus variants may evolve after vaccination. We previously presented a conditional-live HIV-1 variant of which replication can be switched off as an alternative vaccination strategy. To improve the safety of such a vaccine, we constructed a new HIV-1 variant that depends not only on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
